Market Wrap – July 9, 2025 | Global Geopolitical Drama, Tariff Shocks, and Sector-Specific Action
Indian markets on July 9, 2025, saw mixed moods with global geopolitical news colliding with sector-specific corporate events. Investors remained guarded following broad tariff announcements by the US, even as domestic leads in steel, banking, and real estate provided some relief.
Global Cues and Commodities: A Storm Brewing
Crude oil ranged from USD 69.99 per barrel, which shows a risk-averse but stable energy market. Indian Rupee ranged to Rs 85.83 per USD, which indicates no pressure from worldwide uncertainties.
-
Gold reached Rs 96,300 per 10 gm, and silver reached Rs 1,07,800 per kg, which shows a typical safe-haven flip by investors. -
US Dollar Index was at 97.26, while the yield on 10-year bond was at 4.41%, both suggesting a stronger US currency. -
On the base metals front, there was a bearish trend prevalent, as copper inventory surge negated price impact of new US tariffs.

Trump’s Tariff Tsunami: 200% on Pharma, 50% on Copper

The US President Donald Trump imposed a 200% tariff on drug imports and a 50% tariff on copper with special focus on BRICS and Latin American countries.
While politically driven before the election cycle, the effect is set to be strong for Indian pharma exports. Copper markets remained, however, insusceptible to inventory overhang.
Market Insight: Long-term drivers of top Indian exporters remain intact even though pharma and metal stocks will probably continue to be pressured in the near term.
Steel Sector Witnesses Production Hike
-
JSW Steel posted a 14% YoY rise in crude steel output at 7.26 million tonnes (MT).
-
India’s overall steel production grew 15% to 7.02 MT, driven by robust domestic consumption and firm export volumes. -
Tata Steel, on the other hand, logged 5.26 MT of domestic production, while delivery volumes fell 3.8% to 4.75 MT.

⚡ Investor Note: JSW is still a safe bet at 87% capacity utilization. Tata’s delivery fall can be transient given inventory management.
Earnings Snapshot: 5paisa Disappoints
5paisa Capital, an online brokerage, logged dismal Q1FY26 numbers:

-
Profit fell from Rs 20 crore to Rs 12 crore -
Revenue fell from Rs 102 crore to Rs 78 crore -
EBITDA margin dipped from 36.3% to 32.4% -
The decline could be due to a declining active trader base or an increase in operating expenses.
Realty & Infra Updates: Chembur Redevelopment to Drive Momentum
-
Puravankara Ltd received an order for the redevelopment of 8 residential societies at Chembur, Mumbai. The gross development value (GDV) is worth Rs 2,100 crore, a big order win for the developer in the high-end MMR belt.
-
Signature Global posts 15% pre-sales growth at Rs 2,640 crore, with strong realization of Rs 16,296 per sq. ft. -
Supreme Industries secured an order of Rs 54 crore from BPCL for 2 lakh LPG composite cylinders, to be delivered within 6 months.
Orders Galore: Infra & Capital Goods in Focus
-
CMEK secured an ONGC order worth Rs 39 crore for offshore platform repair. -
CEINSYS secured a Rs 115 crore order from MMRDA. -
Dixon Technologies formed a 50:50 JV with SIGNIFY INNOVATION under the brand name “LIGHTANIUM Technology”. -
E-PACK Durable has started manufacturing washing machines at its plant in Andhra Pradesh.

IPO Radar: Anthem Biosciences – Rs 3395 Cr Offer
Anthem Biosciences has launched its Rs 3,395 crore IPO (all OFS), opening on July 14-16, at a price band of Rs 540 to Rs 570 per share.
The company, established in 2006, has business in drug discovery, biosimilars, enzymes, and probiotics and has 975 clients across 44 countries.
FY25 Financials:

-
Revenue: Rs 1,930.29 crore -
Profit: Rs 451.26 crore -
EBITDA Margin: 36.81% -
Patents: 1 in India, 7 overseas, and 24 pending
IPO Expectation: Strong fundamentals, high-margin business, global presence, and strong IP pipeline make it a strong long-term bet.
Banking & PSU Recap
-
Union Bank deposits rose 3.6% to Rs 12.4 lakh crore, and overall business went up 5% to Rs 22.1 lakh crore. Domestic retail deposits saw the maximum growth. -
Tamil Nadu Mercantile Bank has announced a dividend of Rs 11, record date August 1. -
Shree Digvijay Cement has set its dividend record date at August 22.

Healthcare & Biotech News

-
Lupin inked an agreement with ZENTIVA to market its biosimilar CERTOLUMAZUB PEGOL for autoimmune conditions.
-
Shalby Hospitals formed a tie-up with Shri Vaishnav Vidyapeeth University, Indore, for a new healthcare management course.
Other Notable News
-
Bajel Projects to invest Rs 170 crore in its Ranjangaon unit, ushering energy and EPC capacity addition.
-
Blue Star has planned for an ambitious 15% market share with the assistance of new deep freezer models and 4,000 distribution channels. -
Dry bulk volumes of Gujarat Pipavav Port were stable (0.55 MT), container traffic marginally lower (1.64 lakh TEU), and liquid cargo increased to 0.41 MMT.

Sectoral Trends & Index Movement
The session saw profit booking in:

-
Realty -
Metals -
Oil & Gas -
IT -
Infra -
PSU stocks
However, there was buying interest in:
-
FMCG -
Auto -
Pharma

Index Closings:

-
Sensex: 83,536 -
Nifty: 25,476 -
Bank Nifty: 57,213
Conclusion: Volatility with Pockets of Opportunity
Although India Inc. demonstrated resilience to global tariff dislocations and bifurcated sectoral performance, long-term growth is resilient with marquee IPOs such as Anthem Biosciences and strong order bookings in steel, infra, and consumer durables.
Investors need to be careful about US policy risks and geo-political noise, particularly when it comes to pharma and export-oriented businesses.

Disclaimer
Barawakar does not provide financial advice and the information on the website www.Barawakar.com is only for general use. Users of Barawakar accept full responsibility in the possibility of losing capital. Barawakar strives to provide correct information, but offers no guarantees regarding the accuracy or completeness of data given.
In case of any investments planning, make sure to seek professional counsel or do amplify your own research. The www.barawakar.com website is available to users without warranties on availability or functionality. By using this website, you accept the terms of these conditions.
For any questions, feel free to reach out to us.